secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001493152-25-009690
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD Q4 revenue $64.3M (+43% YoY), adj EBITDA $9.0M; FY2025 rev guidance $265-275M
--------------------------------------------------------------------------------

- Q4 2024 revenue $64.3M (+43% YoY); telehealth revenue $49.9M (+60%); GAAP net loss narrowed to $0.9M from $4.5M.
- Adjusted EBITDA $9.0M, up 78% from $5.0M; telehealth adj EBITDA surged 396% to $5.9M.
- Telehealth active subscribers 275k (+27% YoY); WorkSimpli subscribers 164k (+3%, sequentially up 3k).
- Full-year 2025 guidance: revenue $265-275M, adj EBITDA $30-32M; expects gross margin 88-90%.
- Ended 2024 with $35M cash; introduced Q1 2025 guidance rev $61-63M, adj EBITDA $5-7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000149315225009690/0001493152-25-009690-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000149315225009690/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009690

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer